Stella Pharma (TSE:4888) Institutional Ownership: 0.09% (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4888 Stella Pharma Corp TSE:4888
77 GF Score
Price 円340.00
GF Value 円369.89
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Stella Pharma Institutional Ownership?

Stella Pharma TSE:4888 +0.29% 77 Institutional Ownership is 0.09% as of Aug. 19, 2026. GuruFocus rates TSE:4888 with a GF Score™ of 77/100 and a GF Value™ of 円369.89 (Fairly Valued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Stella Pharma's institutional ownership is 0.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Stella Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Stella Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Stella Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Stella Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stella Pharma Institutional Ownership Chart

Stella Pharma Historical Data

The historical data trend for Stella Pharma can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 2.12 2.11 1.91 1.89 1.89 1.87 1.87 1.86 1.76 0.09
TSE:4888
77GF Score
Stella Pharma Corp TSE:4888
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stella Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.09% mean?
Stella Pharma (TSE:4888) has a Institutional Ownership of 0.09% as of Aug. 19, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Stella Pharma and its competitors.
Is Stella Pharma's Institutional Ownership too high?
Stella Pharma's current Institutional Ownership is 0.09%. Overall, Stella Pharma has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stella Pharma's Institutional Ownership compare to VRTX and REGN?
Stella Pharma's Institutional Ownership of 0.09% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Stella Pharma and its competitors. Stella Pharma's current Institutional Ownership is 0.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stella Pharma stock overvalued right now?
Based on GuruFocus' analysis, Stella Pharma (TSE:4888) is currently considered Fairly Valued. The stock's GF Value™ is 円369.89, compared to a current price of 円340.00 — trading 8.1% below its estimated fair value. The current Institutional Ownership is 0.09%. Stella Pharma's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Stella Pharma (TSE:4888), the current Institutional Ownership is 0.09% as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stella Pharma (TSE:4888) Overvalued in 2026?

Based on GuruFocus' analysis, Stella Pharma stock appears to be undervalued. The current stock price of 円340.00 is trading 8.1% below its estimated GF Value™ of 円369.89. GuruFocus considers Stella Pharma to be Fairly Valued.

Key valuation signals for TSE:4888:

  • Institutional Ownership: 0.09%
  • GF Value™: 円369.89 vs. price of 円340.00 (8.1% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the TSE:4888 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stella Pharma Business Description

Address 3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
77GF Score

Get the complete analysis for TSE:4888

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円340.00
Price
円369.89
GF Value